Larvol Delta - aTyr-Pharma-Receives-FDA-Fast-Track-Designation-for-Efzotimod-for-Treatment-of-Systemic-SclerosisAssociated-Interstitial-Lung-Disease-SScILD

Stalaris (efzofitimod) - aTyr Pharma, Kyorin

https://www.globenewswire.com/news-release/2022/09/13/2514942/0/en/aTyr-Pharma-Receives-FDA-Fast-Track-Designation-for-Efzofitimod-for-Treatment-of-Systemic-Sclerosis-Associated-Interstitial-Lung-Disease-SSc-ILD.html

Sep 13, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next